A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, Wappenschmidt B, Volkmann J, Varon R, Weber BH, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Burwinkel B.
Yang R, et al. Among authors: hemminki k.
Breast Cancer Res Treat. 2010 Jun;121(3):693-702. doi: 10.1007/s10549-009-0633-5. Epub 2009 Nov 18.
Breast Cancer Res Treat. 2010.
PMID: 19921425